THC Therapeutics, Inc. financial data

Symbol
THCT on OTC
Location
11700 W Charleston Blvd #73, Las Vegas, NV
Fiscal year end
July 31
Former names
HARMONIC ENERGY, INC. (to 10/29/2014), Aviation Surveillance Systems, Inc. (to 7/26/2010), Fairytale Ventures Inc (to 3/10/2009)
Latest financial report
10-Q - Q4 2023 - Sep 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.04 % -95.5%
Quick Ratio 0 %
Debt-to-equity -97.5 % +3.14%
Return On Assets -4.34K % -647%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.2M shares
Common Stock, Shares, Outstanding 32.7M shares -4.1%
Entity Public Float 3.01M USD 0%
Common Stock, Value, Issued 32.7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 32.9M shares +1.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
General and Administrative Expense 7.48K USD -87.1%
Operating Income (Loss) -253K USD +75.6%
Nonoperating Income (Expense) 970K USD
Net Income (Loss) Attributable to Parent -573K USD +21.3%
Earnings Per Share, Basic -0.09 USD/shares +10%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15K USD +293%
Inventory, Net 0 USD
Other Assets, Current 995 USD
Assets, Current 3.51K USD -66%
Property, Plant and Equipment, Net 0 USD
Intangible Assets, Net (Excluding Goodwill) 11.3K USD -11%
Assets 14.8K USD -35.7%
Liabilities, Current 3.81M USD +15.7%
Liabilities 3.81M USD +15.7%
Retained Earnings (Accumulated Deficit) -39.1M USD -1.49%
Stockholders' Equity Attributable to Parent -3.9M USD -15.5%
Liabilities and Equity 14.8K USD -35.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -269 USD +98.7%
Net Cash Provided by (Used in) Financing Activities 269 USD -98.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 32.7M shares -4.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 0 USD -100%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.51K USD -60.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 8.07M USD +1.02%
Deferred Tax Assets, Gross 8.07M USD +1.02%
Depreciation 0 USD -100%
Preferred Stock, Shares Issued 226K shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 41.3M USD +0.12%
Preferred Stock, Shares Outstanding 226K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 78.4K USD +12.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%